These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4103276)

  • 1. Prevention of Rh-haemolytic disease: final results of the "high-risk" clinical trial. A combined study from centres in England and Baltimore.
    Br Med J; 1971 Jun; 2(5762):607-9. PubMed ID: 4103276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Rh-haemolytic disease: results of the Liverpool "low-risk" clinical trial.
    Woodrow JC; Clarke CA; McConnell RB; Towers SH; Donohoe WT
    Br Med J; 1971 Jun; 2(5762):610-2. PubMed ID: 4103277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Rh-haemolytic disease: results of the clinical trial. A combined study from centres in England and Baltimore.
    Br Med J; 1966 Oct; 2(5519):907-14. PubMed ID: 4162098
    [No Abstract]   [Full Text] [Related]  

  • 4. Rh-immunization by pregnancy: results of a survey and their relevance to prophylactic therapy.
    Woodrow JC; Donohoe WT
    Br Med J; 1968 Oct; 4(5624):139-44. PubMed ID: 4176073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Rh haemolytic disease.
    Clarke CA
    Nurs Mirror Midwives J; 1974 Oct; 139(17):57-9. PubMed ID: 4139694
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of maternal immunization to fetal antigen D].
    Spensieri S; Storace A; Perasso F; Carnevale-Arella E; Bastiani G; De Geronimi GC
    Minerva Ginecol; 1971 Mar; 23(5):234-50. PubMed ID: 4103431
    [No Abstract]   [Full Text] [Related]  

  • 7. [Our experiences in the prevention of Rh sensitization].
    Mikulandra F; Kapitanović IM
    Bilt Hematol Transfuz; 1975; 3(3):65-8. PubMed ID: 57776
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of Rh immunization by anti-D globulin injection after birth and abortion].
    Vardy J; Halbrecht I
    Harefuah; 1972 Aug; 83(3):115-20. PubMed ID: 4118291
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of Rho(D) immune globulin (human) in Canada.
    Bryant EC; Hart GD; Cairns D; Gamarra JA; de Veber LL; Holland CG; Hutchison JL
    Can Med Assoc J; 1969 Dec; 101(12):82-3. PubMed ID: 4188450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunology of Rh-haemolytic disease: a review.
    Schiff P
    Med J Aust; 1969 Nov; 2(18):915-9. PubMed ID: 4187850
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of Rh hemolytic disease of the newborn.
    Jennings ER; Dibbern HH; Hodell FH; Monroe CH; Peckham NH; Sullivan JF; Pollack W
    Calif Med; 1969 Feb; 110(2):130-3. PubMed ID: 4181977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of clinical trials of RhoGAM in women.
    Pollack W; Gorman JG; Freda VJ; Ascari WQ; Allen AE; Baker WJ
    Transfusion; 1968; 8(3):151-3. PubMed ID: 4173363
    [No Abstract]   [Full Text] [Related]  

  • 13. [Information on Rh-D factor of women who have given birth in our obstetrical department].
    Kogoj-Bakić V; Vujaklija-Stipanović IK
    Bilt Hematol Transfuz; 1975; 3(3):61-4. PubMed ID: 57775
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rh-antibodies in women receiving preventive treatment against Rh-immunization. Experiences after 2 years preventive program].
    Orjasaeter H
    Tidsskr Nor Laegeforen; 1972 Dec; 92(35):2412-4. PubMed ID: 4120943
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of Rh prophylaxis.
    Woodrow JC
    Haematologia (Budap); 1974; 8(1-4):281-90. PubMed ID: 4218822
    [No Abstract]   [Full Text] [Related]  

  • 16. Long Beach (California) experience with Rh immunoglobulin.
    Jennings ER; Dibbern HH; Hodell FH; Monroe CH; Peckham NH; Sullivan JF; Pollack W
    Transfusion; 1968; 8(3):146-8. PubMed ID: 4174356
    [No Abstract]   [Full Text] [Related]  

  • 17. One millilitre injections of Rh (D) immune globulin (human) in prevention of Rh immunization. A further report on the clinical trial.
    Bishop GJ; Krieger VI
    Med J Aust; 1969 Jul; 2(4):171-4. PubMed ID: 4184972
    [No Abstract]   [Full Text] [Related]  

  • 18. A clinical trial of anti-Rho(D) immunoglobulin in the prevention of Rho(D) immunization.
    Robertson JG; Holmes CM
    J Obstet Gynaecol Br Commonw; 1969 Mar; 76(3):252-9. PubMed ID: 4180703
    [No Abstract]   [Full Text] [Related]  

  • 19. Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy. Report to the Medical Research Council by the working party on the use of anti-D-immunoglobulin for the prevention of isoimmunization of Rh-negative women during pregnancy.
    Br Med J; 1974 Apr; 2(5910):75-80. PubMed ID: 4207590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liverpool experience with Rh immunoglobulin.
    Finn R
    Transfusion; 1968; 8(3):148-9. PubMed ID: 4173361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.